Categories

What is GeneSight? GeneSight Psychotropic is a laboratory developed genetic test that looks at many of the genes involved when your body processes certain types of medicines.  It is the only genetic test that provides this combined view to help your healthcare provider know which medicines may be a match for your genes. GeneSight gives…

Continue Reading

Extracting your own DNA

Extract your own DNA at home! DNA, or Deoxyribonucleic acid, is the hereditary information in humans and most other plants and animals.  Nearly every cell in a person’s body has the same DNA.  It is made up of four chemical bases called adenine (A), cytosine (C), guanine (G), and thymine (T). Human DNA consists of…

Continue Reading

Improving precision matters in prostate cancer    Understanding the risk of prostate cancer is very important for men ages 40 and older. Myriad Genetics created this infographic to answer a person’s four most pressing questions about prostate cancer. What are your risks of prostate cancer? Do you have prostate cancer? How aggressive is your prostate cancer?…

Continue Reading

The strong culture of Myriad is a critical component of our company’s success.  Today, we are launching an Employee Spotlight!  It’s a way for Myriad to introduce the world to the wonderful people that make our company so fantastic. These Spotlights will be promoted via social media and will highlight several employees over time –…

Continue Reading

Endopredict Patient Types

Introducing a More Accurate Breast Cancer Diagnostic Test We are very excited to announce the launch of EndoPredict in the U.S.! This second-generation test provides more accurate 10-year recurrence risk for patients diagnosed with ER+ HER2- Early-Stage Breast Cancer. Read more here: https://myriad.com/investors/press-release-detail/?newsItemId=1017053 To learn more about EndoPredict, click here: http://endopredictusa.com/ EndoPredict’s accurate low-risk assessment can help…

Continue Reading

March is Colon Cancer Awareness Month and it’s a good time to learn about hereditary colon cancer and how to lower the risk of developing cancer. Hereditary colon cancer accounts for five to 10 percent of all colon cancer and is caused by a genetic mutation that is inherited from either parent. Early occurrence (50 years…

Continue Reading

Understanding your risk for hereditary cancer is an important step in preventing cancer. Myriad Genetics has put together this new infographic on the importance of knowing your family history of cancer, so that you can understand your potential risks. Additionally, if you’re looking for more information on cancer prevention, we have a 30-second Hereditary Cancer…

Continue Reading

A variety of fine English foods With Victoria Sponge Cake, clotted crème, and Branston pickle on their lips a small group of colleagues from across Myriad Genetics sat down for High Tea and a conversation with Jerry Lanchbury, Ph.D., Myriad’s accomplished chief scientific officer. High Tea is an English tradition dating back to 1825 (Click…

Continue Reading

EVP for Emerging Products Patrick Burke notes that our research and development model requires us to rely on collaborations with academics and pharmaceutical companies to help find answers to pressing medical questions.

Continue Reading

Dr. Johnathan Lancaster talks about Myriad’s policies on patient privacy and access to their personal genetic test results. “Myriad believes that a patient’s genetic information is private and confidential. Genetic test results can only be shared with the patient, anyone the patient designates or their healthcare provider.”

Continue Reading